BibTex RIS Cite

Carbamazepine and Resistant Hypocalcemia

Year 2007, Volume: 12 Issue: 1, 79 - 80, 01.02.2007

Abstract

The patient, who was diagnosed epilepsy eight years ago, has been observed since then. The patient has been using carbamezapine for the last three years. He who did not have any seizures in the last year was clinically diagnosed status epilepticus. Status epilepticus was determined to have resulted from severe hypocalcemia. ©2007, Firat University, Medical Faculty

References

  • AndersenRS, ValeurN. Hyperparathyroidism secondary to anticonvulsant treatment. UgeskrLaeger 2001; 163: 6288-6289.
  • Zdrojewicz Z, Dubinski A, Jonek A, Tomanek N, Krajewski W Tetanic crisis and antiepileptic drugs. A case report. Neuro Endocrinol Lett 2005; 26: 317-319.
  • Pack AM Bone disease in epilepsy. Curr Neurol Neurosci Rep 2004; 4: 329-334.
  • Ali FE, Al-Bustan MA, Al-Busairi WA, Al-Mulla FA. Loss of seizure control due to anticonvulsant-induced hypocalcemia. Ann Pharmacother 2004; 38: 1002-1005.
  • Kayemba Kay'S S, Beust M, Aboulghit H, Voisin M, Mourtada A. Carbamazepine and vigabatrin in epileptic pregnant woman and side effects in the newborn infant. Arch Pediatr 1997; 4: 975- 978.
  • Hoikka V, Alhava EM, Karjalainen P, et al. Carbamazepine and bone mineral metabolism. Acta Neurol Scand 1984 ; 70: 77-80.
  • Boran P, Yılmaz Y, Turan S, Bereket A. Karbameazepin ve Valproat monoterapilerinin tiroid fonksiyonu, lipid ve kemik metabolizması üzerine etkileri. Çocuk Dergisi (Logos) 2004; 4: 157-162.
  • Aka S, Erverdi D, Göğcü Ş, Demirkol A, Yavrucu S, Özgüner A. Antiepileptik ilaç kullanan çocuklarda serum kalsiyum düzeyleri. PTT Hastanesi Tıp Dergisi 2000; 22: 154-156.
  • LA Fıtzpatrick. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsi & Behavior 2004; 5: 3- 15.
  • Kabul Tarihi: 15.12.2006

Karbamezapin ve Dirençli Hipokalsemi

Year 2007, Volume: 12 Issue: 1, 79 - 80, 01.02.2007

Abstract

Kliniğimizde sekiz yıldır epilepsi tanısı ile izlenen hasta, son üç yıldır karbamazepin kullanıyordu ve son bir yıldır da hiç nöbeti yokken status epileptikus kliniği ile başvurdu. Status epileptikusun ağır hipokalsemiden kaynaklandığı belirlendi. ©2007, Fırat Üniversitesi, Tıp Fakültesi

References

  • AndersenRS, ValeurN. Hyperparathyroidism secondary to anticonvulsant treatment. UgeskrLaeger 2001; 163: 6288-6289.
  • Zdrojewicz Z, Dubinski A, Jonek A, Tomanek N, Krajewski W Tetanic crisis and antiepileptic drugs. A case report. Neuro Endocrinol Lett 2005; 26: 317-319.
  • Pack AM Bone disease in epilepsy. Curr Neurol Neurosci Rep 2004; 4: 329-334.
  • Ali FE, Al-Bustan MA, Al-Busairi WA, Al-Mulla FA. Loss of seizure control due to anticonvulsant-induced hypocalcemia. Ann Pharmacother 2004; 38: 1002-1005.
  • Kayemba Kay'S S, Beust M, Aboulghit H, Voisin M, Mourtada A. Carbamazepine and vigabatrin in epileptic pregnant woman and side effects in the newborn infant. Arch Pediatr 1997; 4: 975- 978.
  • Hoikka V, Alhava EM, Karjalainen P, et al. Carbamazepine and bone mineral metabolism. Acta Neurol Scand 1984 ; 70: 77-80.
  • Boran P, Yılmaz Y, Turan S, Bereket A. Karbameazepin ve Valproat monoterapilerinin tiroid fonksiyonu, lipid ve kemik metabolizması üzerine etkileri. Çocuk Dergisi (Logos) 2004; 4: 157-162.
  • Aka S, Erverdi D, Göğcü Ş, Demirkol A, Yavrucu S, Özgüner A. Antiepileptik ilaç kullanan çocuklarda serum kalsiyum düzeyleri. PTT Hastanesi Tıp Dergisi 2000; 22: 154-156.
  • LA Fıtzpatrick. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsi & Behavior 2004; 5: 3- 15.
  • Kabul Tarihi: 15.12.2006
There are 10 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Abdullah Kurt This is me

Ayşegül Neşe Çıtak Kurt This is me

Mustafa Aydın This is me

Nimet Kabakuş This is me

Publication Date February 1, 2007
Published in Issue Year 2007 Volume: 12 Issue: 1

Cite

APA Kurt, A., Kurt, A. N. Ç., Aydın, M., Kabakuş, N. (2007). Karbamezapin ve Dirençli Hipokalsemi. Fırat Tıp Dergisi, 12(1), 79-80.
AMA Kurt A, Kurt ANÇ, Aydın M, Kabakuş N. Karbamezapin ve Dirençli Hipokalsemi. Fırat Tıp Dergisi. February 2007;12(1):79-80.
Chicago Kurt, Abdullah, Ayşegül Neşe Çıtak Kurt, Mustafa Aydın, and Nimet Kabakuş. “Karbamezapin Ve Dirençli Hipokalsemi”. Fırat Tıp Dergisi 12, no. 1 (February 2007): 79-80.
EndNote Kurt A, Kurt ANÇ, Aydın M, Kabakuş N (February 1, 2007) Karbamezapin ve Dirençli Hipokalsemi. Fırat Tıp Dergisi 12 1 79–80.
IEEE A. Kurt, A. N. Ç. Kurt, M. Aydın, and N. Kabakuş, “Karbamezapin ve Dirençli Hipokalsemi”, Fırat Tıp Dergisi, vol. 12, no. 1, pp. 79–80, 2007.
ISNAD Kurt, Abdullah et al. “Karbamezapin Ve Dirençli Hipokalsemi”. Fırat Tıp Dergisi 12/1 (February 2007), 79-80.
JAMA Kurt A, Kurt ANÇ, Aydın M, Kabakuş N. Karbamezapin ve Dirençli Hipokalsemi. Fırat Tıp Dergisi. 2007;12:79–80.
MLA Kurt, Abdullah et al. “Karbamezapin Ve Dirençli Hipokalsemi”. Fırat Tıp Dergisi, vol. 12, no. 1, 2007, pp. 79-80.
Vancouver Kurt A, Kurt ANÇ, Aydın M, Kabakuş N. Karbamezapin ve Dirençli Hipokalsemi. Fırat Tıp Dergisi. 2007;12(1):79-80.